Cemex SAB de CV
CXMSF- Exchange
- OTC
- Industry
- Cement, Hydraulic
- SEC CIK
- 0001076378
No open-market purchases or sales by Cemex SAB de CV insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Other share classesCX
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:20 PM ET
Revenue flow, FY2024
Where the revenue went in FY2024, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Revenue | $16.2B | $17.4B | $15.6B | $14.5B | $13.0B |
| Cost of revenue | $10.8B | $11.5B | $10.8B | $9.88B | $8.79B |
| Gross profit | $5.44B | $5.86B | $4.82B | $4.67B | $4.18B |
| Operating expenses | $3.61B | $3.75B | $3.26B | $2.94B | $2.84B |
| Selling, general and administrative | $1.77B | $1.80B | $1.44B | $1.30B | $1.08B |
| Operating income | $1.82B | $1.85B | $1.09B | $1.62B | -$436.0M |
| Income tax | $67.0M | $1.25B | $209.0M | $144.0M | $52.0M |
| Net income | $960.0M | $199.0M | $885.0M | $778.0M | -$1.45B |
| EPS, basic | $0.0217 | $0.0042 | $0.0197 | $0.0171 | $-0.0332 |
| EPS, diluted | $0.0213 | $0.0041 | $0.0193 | $0.0168 | $-0.0332 |
| Weighted shares, basic | 43.4B | 43.5B | 43.6B | 44.1B | 44.1B |
| Weighted shares, diluted | 44.1B | 44.1B | 44.3B | 44.9B | 44.9B |
| Margins and growth | |||||
| Gross margin | 33.6% | 33.7% | 31.0% | 32.1% | 32.2% |
| Operating margin | 11.2% | 10.6% | 7.0% | 11.1% | -3.4% |
| Net margin | 5.9% | 1.1% | 5.7% | 5.3% | -11.1% |
| Revenue growth, year over year | −6.8% | +11.6% | +7.1% | +12.2% | −1.2% |
| Net income growth, year over year | +382.4% | −77.5% | +13.8% | – | −907.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Cash and equivalents | $864.0M | $624.0M | $495.0M | $613.0M | $950.0M |
| Accounts receivable | $1.58B | $1.75B | $1.64B | $1.52B | $1.53B |
| Inventory | $1.49B | $1.79B | $1.67B | $1.26B | $971.0M |
| Total current assets | $5.02B | $5.00B | $4.53B | $4.22B | $4.24B |
| Property, plant and equipment | $10.2B | $11.3B | $10.2B | $10.2B | $10.2B |
| Goodwill | $7.44B | $7.67B | $7.54B | $7.98B | $8.51B |
| Intangible assets | $1.92B | $1.86B | $1.75B | $1.78B | $1.75B |
| Total assets | $27.3B | $28.4B | $26.4B | $26.6B | $27.4B |
| Accounts payable | $3.09B | $3.11B | $2.97B | $2.76B | $2.57B |
| Short-term debt | $22.0M | $10.0M | $2.00M | $68.0M | $105.0M |
| Total current liabilities | $6.09B | $6.79B | $5.55B | $5.38B | $5.35B |
| Long-term debt | $5.34B | $6.20B | $6.92B | $7.31B | $9.16B |
| Total liabilities | $14.8B | $16.3B | $15.5B | $16.4B | $18.5B |
| Shareholders' equity | $12.5B | $12.1B | $10.9B | $10.3B | $8.95B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Operating cash flow | $1.89B | $2.16B | $1.48B | $1.85B | $1.58B |
| Capital expenditures | $1.00B | $968.0M | $909.0M | $801.0M | $538.0M |
| Free cash flow | $894.0M | $1.19B | $566.0M | $1.05B | $1.04B |
| Depreciation and amortization | $1.25B | $1.23B | $1.12B | $1.13B | $1.12B |
| Dividends paid | $90.0M | – | – | – | – |
| Share buybacks | – | $0 | $111.0M | $0 | $83.0M |
| Investing cash flow | -$328.0M | -$1.34B | -$732.0M | -$285.0M | $88.0M |
| Financing cash flow | -$1.25B | -$701.0M | -$961.0M | -$1.85B | -$1.50B |
| Net change in cash | $259.0M | $118.0M | -$223.0M | -$310.0M | $155.0M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.